Molecules/SEVIRUMAB

SEVIRUMAB

Molecular Identity

AntibodyPhase 2

Mechanism of action: Envelope glycoprotein H inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

EV2-7MSL-109PROTOVIRSDZ MSL 109SDZ-MSL-109SEVIRUMAB

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to SEVIRUMAB

Loading drug network...